Activation of tumour cell ECM degradation by thrombin-activated platelet membranes: potentially a P-selectin and GPIIb/IIIa-dependent process.
about
Cancer and Thrombosis: The Platelet Perspective.Hodgkin lymphoma cell lines bind to platelets. Incubation with platelets induces CD15 and P-selectin dependent adhesion of the cell lines to Human Umbilical Vein Endothelial cells (HUVEC)Thrombin-unique coagulation system protein with multifaceted impacts on cancer and metastasis.The influence of platelet membranes on tumour cell behaviour.Carpe low-dose aspirin: the new anti-cancer face of an old anti-platelet drug.
P2860
Activation of tumour cell ECM degradation by thrombin-activated platelet membranes: potentially a P-selectin and GPIIb/IIIa-dependent process.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Activation of tumour cell ECM ...... GPIIb/IIIa-dependent process.
@en
Activation of tumour cell ECM ...... GPIIb/IIIa-dependent process.
@nl
type
label
Activation of tumour cell ECM ...... GPIIb/IIIa-dependent process.
@en
Activation of tumour cell ECM ...... GPIIb/IIIa-dependent process.
@nl
prefLabel
Activation of tumour cell ECM ...... GPIIb/IIIa-dependent process.
@en
Activation of tumour cell ECM ...... GPIIb/IIIa-dependent process.
@nl
P2093
P2860
P1476
Activation of tumour cell ECM ...... GPIIb/IIIa-dependent process.
@en
P2093
P2860
P2888
P304
P356
10.1007/S10585-015-9722-5
P577
2015-05-16T00:00:00Z